Recombinant human granulocyte stimulating factor how many shots need to be combined with the patient’s specific condition to analyze, such as infection-induced leukopenia may be 1 shot white blood cells will have a significant increase; and acute leukemia patients with myelosuppression after chemotherapy, white blood cells, a severe reduction in the white blood cells, you may need to play a few shots before the white blood cells will have a significant increase in the specific will also vary depending on the differences in the individual’s physical condition. Recombinant human granulocyte stimulating factor is mainly used to promote the increase in the number of neutrophils after bone marrow transplantation, cancer chemotherapy-induced neutropenia, myelodysplastic syndromes, aplastic anemia associated with neutropenia, and congenital, idiopathic neutropenia. Adverse reactions include bone pain, fever, back pain, abnormal liver function, shock, interstitial pneumonitis, acute respiratory distress syndrome, and increased naïve cells. It is contraindicated in allergic persons; persons with severe hepatic, renal, cardiac and pulmonary dysfunction; myeloid leukemia in which there is no significant reduction of naïve cells in the bone marrow as well as myeloid leukemia patients in which bone marrow naïve cells are present in the peripheral blood. This product is generally used in hospitals by healthcare professionals.